Insmed Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Will Lewis
Chief executive officer
US$10.4m
Total compensation
CEO salary percentage | 7.5% |
CEO tenure | 12yrs |
CEO ownership | 0.3% |
Management average tenure | 4.8yrs |
Board average tenure | 10.3yrs |
Recent management updates
Recent updates
Insmed Incorporated's (NASDAQ:INSM) Share Price Not Quite Adding Up
Sep 12Insmed: Brensocatib Propels Stock As Regulatory Milestones Approach
Aug 28Is Insmed (NASDAQ:INSM) A Risky Investment?
Aug 10Insmed Incorporated's (NASDAQ:INSM) 92% Share Price Surge Not Quite Adding Up
May 29Insmed Strikes Gold With Phase 3 Bronchiectasis Win (Rating Upgrade)
May 28Insmed Incorporated (NASDAQ:INSM) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
Feb 25Insmed Incorporated (NASDAQ:INSM) Investors Are Less Pessimistic Than Expected
Dec 18Getting In Cheap On Insmed Incorporated (NASDAQ:INSM) Is Unlikely
Jul 28Calculating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)
Jul 01Would Insmed (NASDAQ:INSM) Be Better Off With Less Debt?
Apr 18A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM)
Feb 23Insmed inks financing agreements to raise $500M
Oct 19Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?
Oct 17An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 46% Undervalued
Sep 20Insmed rises 16% on better-than-expected Q2 result
Aug 04Is Insmed (NASDAQ:INSM) A Risky Investment?
Jun 24CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$803m |
Mar 31 2024 | n/a | n/a | -US$747m |
Dec 31 2023 | US$10m | US$780k | -US$750m |
Sep 30 2023 | n/a | n/a | -US$724m |
Jun 30 2023 | n/a | n/a | -US$696m |
Mar 31 2023 | n/a | n/a | -US$547m |
Dec 31 2022 | US$8m | US$735k | -US$482m |
Sep 30 2022 | n/a | n/a | -US$434m |
Jun 30 2022 | n/a | n/a | -US$416m |
Mar 31 2022 | n/a | n/a | -US$438m |
Dec 31 2021 | US$7m | US$710k | -US$435m |
Sep 30 2021 | n/a | n/a | -US$424m |
Jun 30 2021 | n/a | n/a | -US$375m |
Mar 31 2021 | n/a | n/a | -US$319m |
Dec 31 2020 | US$6m | US$660k | -US$294m |
Sep 30 2020 | n/a | n/a | -US$245m |
Jun 30 2020 | n/a | n/a | -US$242m |
Mar 31 2020 | n/a | n/a | -US$247m |
Dec 31 2019 | US$7m | US$641k | -US$254m |
Sep 30 2019 | n/a | n/a | -US$293m |
Jun 30 2019 | n/a | n/a | -US$320m |
Mar 31 2019 | n/a | n/a | -US$330m |
Dec 31 2018 | US$6m | US$610k | -US$324m |
Sep 30 2018 | n/a | n/a | -US$298m |
Jun 30 2018 | n/a | n/a | -US$256m |
Mar 31 2018 | n/a | n/a | -US$224m |
Dec 31 2017 | US$4m | US$567k | -US$193m |
Compensation vs Market: Will's total compensation ($USD10.41M) is about average for companies of similar size in the US market ($USD13.18M).
Compensation vs Earnings: Will's compensation has increased whilst the company is unprofitable.
CEO
Will Lewis (55 yo)
12yrs
Tenure
US$10,411,260
Compensation
Mr. William H. Lewis, also known as Will, J.D. M.B.A. serves as an Independent Chairman of Board of Directors of NewAmsterdam Pharma Company N.V. from January 2024. He has been Chief Executive Officer and...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 12yrs | US$10.41m | 0.26% $ 33.2m | |
Chief Financial Officer | 4.7yrs | US$4.56m | 0.011% $ 1.4m | |
Chief Operating Officer | 4.8yrs | US$4.01m | 0.037% $ 4.7m | |
Chief Commercial Officer | 4.8yrs | US$3.89m | 0.030% $ 3.8m | |
Chief Medical Officer | 4.8yrs | US$4.22m | 0.0074% $ 938.6k | |
Chief Scientific Officer | no data | no data | no data | |
Associate Director of Investor Relations | no data | no data | no data | |
Chief Legal Officer & Corporate Secretary | 3.2yrs | no data | 0.052% $ 6.6m | |
Executive Director of Corporate Communications | no data | no data | no data | |
Chief People Strategy Officer | 11.7yrs | US$2.66m | 0.020% $ 2.5m | |
Chief Product Strategy Officer | 7.3yrs | US$1.69m | no data | |
GM & Head of Europe | 5.3yrs | no data | no data |
4.8yrs
Average Tenure
55yo
Average Age
Experienced Management: INSM's management team is considered experienced (4.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 12yrs | US$10.41m | 0.26% $ 33.2m | |
Independent Director | 10.9yrs | US$320.00k | 0.050% $ 6.3m | |
Independent Director | 23.3yrs | US$312.50k | 0.19% $ 24.0m | |
Independent Director | 12.1yrs | US$320.00k | 0.033% $ 4.2m | |
Lead Independent Director | 10.3yrs | US$345.00k | 0.063% $ 8.0m | |
Independent Director | 4.8yrs | US$315.00k | 0.028% $ 3.6m | |
Independent Director | 5.8yrs | US$310.00k | 0.032% $ 4.1m | |
Independent Director | 6.3yrs | US$317.50k | 0.065% $ 8.2m | |
Independent Director | 4.4yrs | US$315.00k | 0.026% $ 3.3m |
10.3yrs
Average Tenure
65yo
Average Age
Experienced Board: INSM's board of directors are seasoned and experienced ( 10.3 years average tenure).